Trial intelligence / Profile preview

IC-GREEN SPY Imaging for Lymphatic Mapping in Breast Cancer

NCT01771666Phase 2Completed

Sponsor
Stanford University
Start
Jul 2012
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of indocyanine green in breast cancer, sponsored by Stanford University. Started Jul 2012; status: completed.

02

Drugs

indocyanine green
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01771666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01771666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call